Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Cell Cycle Checkpoints/drug effects/genetics"'
Autor:
Christoph Schwärzler, Sylvain Lemeille, Wolf-Henning Boehncke, Hedwig Sutterlüty-Fall, Marylise Fernandez, Rastine Merat
Publikováno v:
Cancer Medicine, Vol. 6, No 7 (2017) pp. 1652-1664
Cancer Medicine
Cancer Medicine
Tumor plasticity and the heterogeneous response of melanoma cells to targeted therapies are major limits for the long‐term efficacy of this line of therapy. Targeting tumor plasticity is theoretically possible through the modulation of the expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39db6c1f4fd5a65b4195357047cb1e95
https://archive-ouverte.unige.ch/unige:106964
https://archive-ouverte.unige.ch/unige:106964
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 2011, 30 (41), pp.4261--74. ⟨10.1038/onc.2011.135⟩
Oncogene, Nature Publishing Group, 2011, 30 (41), pp.4261--74. ⟨10.1038/onc.2011.135⟩
In the presence of sustained DNA damage occurring in S-phase or G2, normal cells arrest before mitosis and eventually become senescent. The checkpoint kinases Chk1/Chk2 and the CDK inhibitor p21 are known to have important complementary roles in this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d676aed23cbb7b053282ee72b12f2b
https://hal.archives-ouvertes.fr/hal-02193324
https://hal.archives-ouvertes.fr/hal-02193324